Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Glaukos: Q2 Earnings Snapshot AP - Wed Jul 29, 4:05PM CDT

Glaukos: Q2 Earnings Snapshot

GKOS : 170.99 (+0.04%)
Glaukos Announces Second Quarter 2026 Financial Results Business Wire - Wed Jul 29, 3:05PM CDT

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 170.99 (+0.04%)
Glaukos Earnings: Whether the iDose Launch Can Justify What's Already Been Priced In Barchart - Tue Jul 28, 4:10PM CDT

Barchart Research What to Expect from GKOS Earnings GKOS Generated July 28, 2026 Current Price $151.33 EPS Estimate $$-0.28 Consensus Rating Strong Buy Average Move 11.64% Glaukos Earnings: Whether the...

GKOS : 170.99 (+0.04%)
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt Business Wire - Mon Jul 27, 6:00AM CDT

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 170.99 (+0.04%)
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29 Business Wire - Wed Jul 8, 6:00AM CDT

Conference Call and Webcast Scheduled for 1:30 p.m. PT

GKOS : 170.99 (+0.04%)
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis Business Wire - Thu Jun 25, 6:00AM CDT

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 170.99 (+0.04%)
Glaukos Announces Participation in Upcoming Investor Conferences Business Wire - Tue May 12, 6:00AM CDT

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 170.99 (+0.04%)
Glaukos: Q1 Earnings Snapshot AP - Wed Apr 29, 3:52PM CDT

Glaukos: Q1 Earnings Snapshot

GKOS : 170.99 (+0.04%)
Glaukos Announces First Quarter 2026 Financial Results Business Wire - Wed Apr 29, 3:05PM CDT

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 170.99 (+0.04%)
Glaukos Reports Tomorrow With Epioxa Launch Metrics Still Unknown Barchart - Tue Apr 28, 4:14PM CDT

Barchart Research What to Expect from GKOS Earnings GKOS Generated April 28, 2026 Current Price $119.63 EPS Estimate $$-0.30 Consensus Rating Strong Buy Average Move 9.55% Glaukos Reports Tomorrow With...

GKOS : 170.99 (+0.04%)

Barchart Exclusives

The Data Center Boom Is Powering Utility Earnings. Here Is My Favorite Way to Play the Trend. Barchart - Thu Aug 6, 6:30PM CDT
Utility companies are increasingly benefiting from the AI data center boom, and here is my favorite way to gain exposure to this investment theme. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.